Moreover, uncommon EGFR mutations, including exon 20 insertions, G719X, S768I, and L861Q, were associated with a favourable response in Chinese NSCLC patients to anti-PD-1/PD-L1. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.